M. Efentakis

942 total citations
33 papers, 787 citations indexed

About

M. Efentakis is a scholar working on Pharmaceutical Science, Molecular Medicine and Organic Chemistry. According to data from OpenAlex, M. Efentakis has authored 33 papers receiving a total of 787 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pharmaceutical Science, 6 papers in Molecular Medicine and 5 papers in Organic Chemistry. Recurrent topics in M. Efentakis's work include Drug Solubulity and Delivery Systems (30 papers), Advanced Drug Delivery Systems (19 papers) and Hydrogels: synthesis, properties, applications (6 papers). M. Efentakis is often cited by papers focused on Drug Solubulity and Delivery Systems (30 papers), Advanced Drug Delivery Systems (19 papers) and Hydrogels: synthesis, properties, applications (6 papers). M. Efentakis collaborates with scholars based in Greece, United Kingdom and United States. M. Efentakis's co-authors include Marilena Vlachou, Graham Buckton, Jennifer Dressman, Stavros Politis, Hani Naseef, A. G. Andreopoulos, P. A. Tarantili, Konstantinos Avgoustakis, Εvangelia Papadimitriou and Yannis L. Loukas and has published in prestigious journals such as International Journal of Pharmaceutics, European Polymer Journal and AAPS PharmSciTech.

In The Last Decade

M. Efentakis

31 papers receiving 713 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Efentakis Greece 17 571 137 128 86 85 33 787
Karen Mitchell United Kingdom 10 464 0.8× 128 0.9× 100 0.8× 65 0.8× 100 1.2× 12 612
Phillip R. Nixon United States 7 468 0.8× 100 0.7× 79 0.6× 69 0.8× 90 1.1× 9 588
A. La Manna Italy 16 607 1.1× 105 0.8× 98 0.8× 77 0.9× 140 1.6× 37 831
P. Prinderre France 11 477 0.8× 102 0.7× 111 0.9× 41 0.5× 51 0.6× 16 653
Marina Levina United Kingdom 17 427 0.7× 111 0.8× 100 0.8× 75 0.9× 36 0.4× 23 624
K.V.Ranga Rao India 11 591 1.0× 128 0.9× 123 1.0× 82 1.0× 109 1.3× 18 751
Yun-Seok Rhee South Korea 20 660 1.2× 99 0.7× 140 1.1× 73 0.8× 45 0.5× 61 1.0k
Nahla S. Barakat Saudi Arabia 17 438 0.8× 110 0.8× 68 0.5× 99 1.2× 39 0.5× 32 658
Vijay B. Sutariya India 11 370 0.6× 65 0.5× 126 1.0× 138 1.6× 111 1.3× 16 749
Sathyanarayana M. Upadrashta United States 14 405 0.7× 89 0.6× 82 0.6× 74 0.9× 37 0.4× 22 534

Countries citing papers authored by M. Efentakis

Since Specialization
Citations

This map shows the geographic impact of M. Efentakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Efentakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Efentakis more than expected).

Fields of papers citing papers by M. Efentakis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Efentakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Efentakis. The network helps show where M. Efentakis may publish in the future.

Co-authorship network of co-authors of M. Efentakis

This figure shows the co-authorship network connecting the top 25 collaborators of M. Efentakis. A scholar is included among the top collaborators of M. Efentakis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Efentakis. M. Efentakis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Efentakis, M., et al.. (2013). Design and evaluation of oral delivery formulations based on dextran with theophylline. International Journal of Phytomedicine. 4(4). 515–522. 1 indexed citations
2.
Efentakis, M., Hani Naseef, & Marilena Vlachou. (2010). Two- and three-layer tablet drug delivery systems for oral sustained release of soluble and poorly soluble drugs. Drug Development and Industrial Pharmacy. 36(8). 903–916. 18 indexed citations
3.
Vlachou, Marilena, Hani Naseef, & M. Efentakis. (2010). Utilization of Hydrophilic Swellable Polymers as Carriers for Sustained Drug Delivery from Matrices and Three Layer Tablet Systems. Current Drug Delivery. 7(4). 334–342. 2 indexed citations
4.
Efentakis, M., et al.. (2010). Effect of core size and excipients on the lag time and drug release from a pulsatile drug delivery system. Drug Development and Industrial Pharmacy. 37(1). 113–120. 9 indexed citations
5.
Efentakis, M., et al.. (2009). An investigation into the swelling properties, dimensional changes, and gel layer evolution in chitosan tablets undergoing hydration. Advances in Polymer Technology. 28(1). 32–39. 4 indexed citations
7.
Efentakis, M., et al.. (2007). Dimensional changes, gel layer evolution and drug release studies in hydrophilic matrices loaded with drugs of different solubility. International Journal of Pharmaceutics. 339(1-2). 66–75. 31 indexed citations
8.
Efentakis, M., et al.. (2006). Design and evaluation of a dry coated drug delivery system with an impermeable cup, swellable top layer and pulsatile release. International Journal of Pharmaceutics. 311(1-2). 147–156. 55 indexed citations
9.
Efentakis, M. & Graham Buckton. (2002). The Effect of Erosion and Swelling on the Dissolution of Theophylline from Low and High Viscosity Sodium Alginate Matrices. Pharmaceutical Development and Technology. 7(1). 69–77. 45 indexed citations
10.
Efentakis, M., et al.. (2001). Release of Furosemide from Multiple-Unit and Single-Unit Preparations Containing Different Viscosity Grades of Sodium Alginate. Pharmaceutical Development and Technology. 6(1). 91–98. 46 indexed citations
11.
Vlachou, Marilena, Hani Naseef, M. Efentakis, P. A. Tarantili, & A. G. Andreopoulos. (2001). Swelling Properties of Various Polymers Used in Controlled Release Systems. Journal of Biomaterials Applications. 15(4). 293–306. 22 indexed citations
12.
Vlachou, Marilena, Hani Naseef, M. Efentakis, P. A. Tarantili, & A. G. Andreopoulos. (2001). Swelling Properties of Various Polymers Used in Controlled Release Systems. Journal of Biomaterials Applications. 16(2). 125–138. 11 indexed citations
13.
14.
Efentakis, M., et al.. (2000). Development and Evaluation of oral multiple-unit and single-unit hydrophilic controlled-release systems. AAPS PharmSciTech. 1(4). 62–70. 71 indexed citations
15.
Efentakis, M. & Jennifer Dressman. (1998). Gastric juice as a dissolution medium: Surface tension and pH. European Journal of Drug Metabolism and Pharmacokinetics. 23(2). 97–102. 73 indexed citations
16.
Antoniadou‐Vyza, Ekaterini, et al.. (1997). The formation of an inclusion complex of methocarbamol with hydroxypropyl-β-cyclodextrin: the effect on chemical stability, solubility and dissolution rate. International Journal of Pharmaceutics. 158(2). 233–239. 21 indexed citations
17.
Efentakis, M., et al.. (1992). The effect of surfactant charge on drug release from acrylic matrices. UCL Discovery (University College London). 2 indexed citations
18.
Buckton, Graham, et al.. (1991). Modelling drug release from matrix formulations by use of thermodynamic activation parameters and extrathermodynamics. UCL Discovery (University College London). 1 indexed citations
19.
Buckton, Graham & M. Efentakis. (1990). The use of thermodynamic activation parameters and compensation analysis to model drug release from hydrophobic matrices. International Journal of Pharmaceutics. 62(2-3). 157–163. 9 indexed citations
20.
Efentakis, M. & Graham Buckton. (1990). Modelling drug release from hydrophobic matrices by use of thermodynamic activation parameters. International Journal of Pharmaceutics. 60(3). 229–234. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026